Showing results (1801-1810 of 2,084) with videos related to

Sort By:
Pageof 209
Acta Neuropathologica|February 1, 2019
ACTN2 mutations cause "Multiple structured Core Disease" (MsCD)Xavière Lornage, Norma B Romero, Claire A Grosgogeat, et al.
Der Nervenarzt|July 6, 2006
[Suggestion for a new, patient-oriented epilepsy classification]C Kellinghaus, T Loddenkemper, E Wyllie, et al.
European Child & Adolescent Psychiatry|May 5, 2019
Development and psychometric properties of the "Suicidality: Treatment Occurring in Paediatrics (STOP) Risk and Resilience Factors Scales" in adolescentsA Rodríguez-Quiroga, I Flamarique, J Castro-Fornieles, et al.
Cerebral Cortex (New York, N.Y. : 1991)|February 11, 2021
Hyperactive MEK1 Signaling in Cortical GABAergic Neurons Promotes Embryonic Parvalbumin Neuron Loss and Defects in Behavioral InhibitionMichael C Holter, Lauren T Hewitt, Kenji J Nishimura, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 26, 2018
Trends in HbA1c levels and implications for diabetes screening in tuberculosis cases undergoing treatment in IndiaA N Gupte, V Mave, S Meshram, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2022
Deciphering radiological stable disease to immune checkpoint inhibitorsJ Luo, S Wu, H Rizvi, et al.
Gut|December 26, 2014
Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registryR J Haidry, M A Butt, J M Dunn, et al.
Pediatrics|February 18, 2026
Demographic Factors and Biliary Atresia: A Childhood Liver Disease Research Network StudyZachary J Kastenberg, Charlotte A Beil, Lisa Henn, et al.
Blood Neoplasia|June 24, 2025
Predictors of response to venetoclax and therapeutic potential of CDK7 inhibition in multiple myelomaRudra P Dutta, Santiago Thibaud, Violetta Leshchenko, et al.
Blood|December 18, 2024
Heme promotes venetoclax resistance in multiple myeloma through MEK-ERK signaling and purine biosynthesisRemya Nair, An H Vu, Abigail K Freer, et al.
Pageof 209